Logo image of PET.CA

PET VALU HOLDINGS LTD (PET.CA) Stock Fundamental Analysis

TSX:PET - CA71584R1055 - Common Stock

39 CAD
+0.35 (+0.91%)
Last: 8/29/2025, 7:00:00 PM
Fundamental Rating

5

Taking everything into account, PET scores 5 out of 10 in our fundamental rating. PET was compared to 17 industry peers in the Specialty Retail industry. While PET has a great profitability rating, there are some minor concerns on its financial health. While showing a medium growth rate, PET is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year PET was profitable.
In the past year PET had a positive cash flow from operations.
Each year in the past 5 years PET has been profitable.
Each year in the past 5 years PET had a positive operating cash flow.
PET.CA Yearly Net Income VS EBIT VS OCF VS FCFPET.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

1.2 Ratios

The Return On Assets of PET (9.65%) is better than 94.12% of its industry peers.
Looking at the Return On Equity, with a value of 166.31%, PET belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
PET has a better Return On Invested Capital (14.44%) than 94.12% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PET is significantly above the industry average of 8.41%.
Industry RankSector Rank
ROA 9.65%
ROE 166.31%
ROIC 14.44%
ROA(3y)10.79%
ROA(5y)10.41%
ROE(3y)9006.4%
ROE(5y)N/A
ROIC(3y)16.85%
ROIC(5y)17.86%
PET.CA Yearly ROA, ROE, ROICPET.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5K 10K 15K 20K 25K

1.3 Margins

The Profit Margin of PET (8.46%) is better than 76.47% of its industry peers.
PET's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 14.36%, PET is doing good in the industry, outperforming 76.47% of the companies in the same industry.
PET's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 33.18%, PET is not doing good in the industry: 64.71% of the companies in the same industry are doing better.
PET's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.36%
PM (TTM) 8.46%
GM 33.18%
OM growth 3Y-5.31%
OM growth 5Y-4.13%
PM growth 3Y-13.45%
PM growth 5Y27.95%
GM growth 3Y-3.52%
GM growth 5Y-1.57%
PET.CA Yearly Profit, Operating, Gross MarginsPET.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so PET is creating value.
Compared to 1 year ago, PET has less shares outstanding
PET has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, PET has an improved debt to assets ratio.
PET.CA Yearly Shares OutstandingPET.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
PET.CA Yearly Total Debt VS Total AssetsPET.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 3.08 indicates that PET is not in any danger for bankruptcy at the moment.
PET's Altman-Z score of 3.08 is fine compared to the rest of the industry. PET outperforms 64.71% of its industry peers.
The Debt to FCF ratio of PET is 5.34, which is a neutral value as it means it would take PET, 5.34 years of fcf income to pay off all of its debts.
PET's Debt to FCF ratio of 5.34 is fine compared to the rest of the industry. PET outperforms 64.71% of its industry peers.
A Debt/Equity ratio of 12.69 is on the high side and indicates that PET has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 12.69, PET is doing worse than 88.24% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 12.69
Debt/FCF 5.34
Altman-Z 3.08
ROIC/WACC1.68
WACC8.61%
PET.CA Yearly LT Debt VS Equity VS FCFPET.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

2.3 Liquidity

A Current Ratio of 1.28 indicates that PET should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.28, PET is in line with its industry, outperforming 58.82% of the companies in the same industry.
PET has a Quick Ratio of 1.28. This is a bad value and indicates that PET is not financially healthy enough and could expect problems in meeting its short term obligations.
PET has a worse Quick ratio (0.51) than 70.59% of its industry peers.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 0.51
PET.CA Yearly Current Assets VS Current LiabilitesPET.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

6

3. Growth

3.1 Past

PET shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.61%.
The Earnings Per Share has been growing by 44.70% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 5.18% in the past year.
The Revenue has been growing by 13.85% on average over the past years. This is quite good.
EPS 1Y (TTM)-3.61%
EPS 3Y-3.16%
EPS 5Y44.7%
EPS Q2Q%0%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.24%
Revenue growth 5Y13.85%
Sales Q2Q%5.81%

3.2 Future

The Earnings Per Share is expected to grow by 10.08% on average over the next years. This is quite good.
Based on estimates for the next years, PET will show a quite strong growth in Revenue. The Revenue will grow by 10.37% on average per year.
EPS Next Y5.88%
EPS Next 2Y9.2%
EPS Next 3Y10.08%
EPS Next 5YN/A
Revenue Next Year8.87%
Revenue Next 2Y7.25%
Revenue Next 3Y7.32%
Revenue Next 5Y10.37%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PET.CA Yearly Revenue VS EstimatesPET.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
PET.CA Yearly EPS VS EstimatesPET.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 24.38, which indicates a rather expensive current valuation of PET.
Based on the Price/Earnings ratio, PET is valued a bit cheaper than the industry average as 70.59% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.08, PET is valued at the same level.
The Price/Forward Earnings ratio is 20.57, which indicates a rather expensive current valuation of PET.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PET indicates a somewhat cheap valuation: PET is cheaper than 70.59% of the companies listed in the same industry.
PET is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.72, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 24.38
Fwd PE 20.57
PET.CA Price Earnings VS Forward Price EarningsPET.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

PET's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PET is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 17.57
EV/EBITDA 15
PET.CA Per share dataPET.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PET does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of PET may justify a higher PE ratio.
PEG (NY)4.14
PEG (5Y)0.55
EPS Next 2Y9.2%
EPS Next 3Y10.08%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.24%, PET has a reasonable but not impressive dividend return.
PET's Dividend Yield is a higher than the industry average which is at 7.67.
With a Dividend Yield of 1.24, PET pays less dividend than the S&P500 average, which is at 2.35.
Industry RankSector Rank
Dividend Yield 1.24%

5.2 History

PET has been paying a dividend for over 5 years, so it has already some track record.
PET has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3
PET.CA Yearly Dividends per sharePET.CA Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

33.86% of the earnings are spent on dividend by PET. This is a low number and sustainable payout ratio.
DP33.86%
EPS Next 2Y9.2%
EPS Next 3Y10.08%
PET.CA Yearly Income VS Free CF VS DividendPET.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
PET.CA Dividend Payout.PET.CA Dividend Payout, showing the Payout Ratio.PET.CA Dividend Payout.PayoutRetained Earnings

PET VALU HOLDINGS LTD

TSX:PET (8/29/2025, 7:00:00 PM)

39

+0.35 (+0.91%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)N/A N/A
Inst Owners37.58%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap2.66B
Analysts80
Price Target42.28 (8.41%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.24%
Yearly Dividend0.44
Dividend Growth(5Y)N/A
DP33.86%
Div Incr Years3
Div Non Decr Years3
Ex-Date08-29 2025-08-29 (0.12)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.39%
Min EPS beat(2)5.61%
Max EPS beat(2)15.17%
EPS beat(4)4
Avg EPS beat(4)12.47%
Min EPS beat(4)5.61%
Max EPS beat(4)17.7%
EPS beat(8)8
Avg EPS beat(8)9.53%
EPS beat(12)11
Avg EPS beat(12)7.49%
EPS beat(16)15
Avg EPS beat(16)13.57%
Revenue beat(2)1
Avg Revenue beat(2)2.88%
Min Revenue beat(2)-1.23%
Max Revenue beat(2)6.99%
Revenue beat(4)2
Avg Revenue beat(4)1.92%
Min Revenue beat(4)-1.23%
Max Revenue beat(4)6.99%
Revenue beat(8)2
Avg Revenue beat(8)0.3%
Revenue beat(12)5
Avg Revenue beat(12)0.86%
Revenue beat(16)9
Avg Revenue beat(16)2.51%
PT rev (1m)18.98%
PT rev (3m)27.73%
EPS NQ rev (1m)-4.03%
EPS NQ rev (3m)-6.96%
EPS NY rev (1m)3.13%
EPS NY rev (3m)3.13%
Revenue NQ rev (1m)0.41%
Revenue NQ rev (3m)1.37%
Revenue NY rev (1m)0.59%
Revenue NY rev (3m)0.67%
Valuation
Industry RankSector Rank
PE 24.38
Fwd PE 20.57
P/S 2.35
P/FCF 17.57
P/OCF 12.52
P/B 46.28
P/tB N/A
EV/EBITDA 15
EPS(TTM)1.6
EY4.1%
EPS(NY)1.9
Fwd EY4.86%
FCF(TTM)2.22
FCFY5.69%
OCF(TTM)3.12
OCFY7.99%
SpS16.57
BVpS0.84
TBVpS-1.34
PEG (NY)4.14
PEG (5Y)0.55
Profitability
Industry RankSector Rank
ROA 9.65%
ROE 166.31%
ROCE 20.12%
ROIC 14.44%
ROICexc 14.65%
ROICexgc 18.02%
OM 14.36%
PM (TTM) 8.46%
GM 33.18%
FCFM 13.4%
ROA(3y)10.79%
ROA(5y)10.41%
ROE(3y)9006.4%
ROE(5y)N/A
ROIC(3y)16.85%
ROIC(5y)17.86%
ROICexc(3y)18.17%
ROICexc(5y)19.94%
ROICexgc(3y)24.29%
ROICexgc(5y)28.59%
ROCE(3y)23.47%
ROCE(5y)24.88%
ROICexcg growth 3Y-19.06%
ROICexcg growth 5Y-10.3%
ROICexc growth 3Y-14.11%
ROICexc growth 5Y-6.19%
OM growth 3Y-5.31%
OM growth 5Y-4.13%
PM growth 3Y-13.45%
PM growth 5Y27.95%
GM growth 3Y-3.52%
GM growth 5Y-1.57%
F-ScoreN/A
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity 12.69
Debt/FCF 5.34
Debt/EBITDA 3.16
Cap/Depr 89.51%
Cap/Sales 5.4%
Interest Coverage 3.83
Cash Conversion 92.19%
Profit Quality 158.42%
Current Ratio 1.28
Quick Ratio 0.51
Altman-Z 3.08
F-ScoreN/A
WACC8.61%
ROIC/WACC1.68
Cap/Depr(3y)113.42%
Cap/Depr(5y)97.58%
Cap/Sales(3y)5.53%
Cap/Sales(5y)4.68%
Profit Quality(3y)104.43%
Profit Quality(5y)210.05%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.61%
EPS 3Y-3.16%
EPS 5Y44.7%
EPS Q2Q%0%
EPS Next Y5.88%
EPS Next 2Y9.2%
EPS Next 3Y10.08%
EPS Next 5YN/A
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.24%
Revenue growth 5Y13.85%
Sales Q2Q%5.81%
Revenue Next Year8.87%
Revenue Next 2Y7.25%
Revenue Next 3Y7.32%
Revenue Next 5Y10.37%
EBIT growth 1Y6.3%
EBIT growth 3Y6.27%
EBIT growth 5Y9.15%
EBIT Next Year50.9%
EBIT Next 3Y19.86%
EBIT Next 5YN/A
FCF growth 1Y136.98%
FCF growth 3Y7.11%
FCF growth 5Y4.84%
OCF growth 1Y68.11%
OCF growth 3Y13.14%
OCF growth 5Y10.94%